Last updated: June 21, 2023
Sponsor: Lille Catholic University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Neurologic Disorders
Memory Loss
Multiple Sclerosis
Treatment
Three dimensional gait analysis with eyetracking
Clinical Study ID
NCT04837365
RC-P00108
Ages 18-55 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Understanding and able to speak French
- Carriers of MS with relapsing remitting form (RRMS-RR) with an EDSS <4
- No significant motor, cerebellar or somesthesia disorders of the upper limbs or visualdisturbances (side to a visual EDSS <2)
- Absence of corticosteroid intake in the last four weeks
- Benefiting from health insurance coverage
- Not showing any flare-ups or worsening of the disease in the last 6 weeks
- No botulinum toxin injection for more than 4 months
Exclusion
Exclusion Criteria:
- People with previous neurological pathologies, head trauma with loss of consciousness,psychiatric pathologies, serious general ailments, perceptual or dysarthric disorderspreventing verbal communication or reading,
- Treatment with psychotropic drugs (except benzodiazepines and hypnotics).
- Refusal to participate after clear and fair information about the study.
- Adults under tutorship, curatorship or safeguard of justice
- With orthopedic treatment influencing walking
- Pregnant woman
Study Design
Total Participants: 20
Treatment Group(s): 1
Primary Treatment: Three dimensional gait analysis with eyetracking
Phase:
Study Start date:
May 21, 2021
Estimated Completion Date:
May 31, 2025
Connect with a study center
St Vincent hospital - neurological service
Lille,
FranceActive - Recruiting
St Philibert hospital - Neurologial service
Lomme,
FranceActive - Recruiting
St Philibert hospital - Physical Medicine and Rehabilitation
Lomme,
FranceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.